<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="itemcontent.css" type="text/css" media="screen"?><rss xmlns:blogChannel="http://backend.userland.com/blogChannelModule" xmlns:source="http://purl.org/my/rss/module/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
    <channel>
        <title>Mass High Tech Newspaper | Mass High Tech: The Voice of New England Innovation</title>
            <link>http://www.masshightech.com/latestnews.html</link>
            <description>Mass High Tech: The Voice of New England Innovation : breaking news from Mass High Tech</description>
            <pubDate>Sat, 11 Feb 2012 01:06:40 -0500</pubDate>
            <language>en-US</language>
            <image>
                <link>http://www.masshightech.com/</link>
                <url>http://www.masshightech.com/images/flag.gif</url>
                <title>Mass High Tech: The Voice of New England Innovation</title>
            </image>
<item>
<title>Russian venture firm puts $100K into MassChallenge 2012</title>
<author>Rodney H. Brown</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily47-Russian-venture-firm-puts-100K-into-MassChallenge-2012.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<description>Less than a month after landing in Boston, the new venture finance firm Russian Venture Co. U.S.A. has committed to being a platinum level sponsor of the MassChallenge 2012, which brings along a $100,000 investment by RVC-USA in the Boston-based startup competition. </description>
</item>
<item>
<title>Synageva advances rare disease treatment</title>
<author>Michelle Lang</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily46-Synageva-advances-rare-disease-treatment.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619986.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619986.jpg">
</media:content>
<description>Synageva BioPharma Corp. has returned encouraging results of a Phase 1/2 clinical trial of its lead program, SBC-102, in treating late onset Lysosomal Acid Lipase Deficiency, also known as Cholesteryl Ester Storage Disease, affecting both children and adults.</description>
</item>
<item>
<title>Post-buyout, Atrium Medical plans new site</title>
<author>Michelle Lang</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily45-Post-buyout-Atrium-Medical-plans-new-site.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619985.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619985.jpg">
</media:content>
<description>Atrium Medical Corp., the Hudson, N.H.-based medical devices firm acquired by Swedish company Getinge Group in October, will not be building a new facility in Merrimack, N.H. Instead, the company will look to occupy an existing facility in Merrimack, according to a published report.</description>
</item>
<item>
<title>Zalicus, Hydra team up on pain treatment</title>
<author>Rodney H. Brown</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily44-Zalicus-Hydra-team-up-on-pain-treatment.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619984.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619984.jpg">
</media:content>
<description>Zalicus Inc., the biopharmaceutical company formerly known as CombinatoRx, has teamed up with Cambridge neighbor Hydra Biosciences Inc. to move forward Zalicus’ pain treatment candidates.</description>
</item>
<item>
<title>Alnylam to speed lead drug candidates' development</title>
<author>Lori Valigra</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily43-Alnylam-to-speed-lead-drug-candidates-development.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619982.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619982.jpg">
<media:text>Barry Greene, president and chief operating officer, Alnylam Pharmaceuticals</media:text>
</media:content>
<description>Alnylam Pharmaceuticals Inc. of Cambridge said it will accelerate develop of two lead drug candidates that offer the greatest commercial opportunity, and that it has discovered a novel method to monitor the activity of RNAi in blood samples and granted the first license to Isis Pharmaceuticals.</description>
</item>
<item>
<title>Ironwood stock offering aims for $80M</title>
<author>Michelle Lang</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily42-Ironwood-stock-offering-aims-for-80M.html</link>
<pubDate>Fri, 10 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619981.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619981.jpg">
</media:content>
<description>Ironwood Pharmaceuticals Inc. has priced a public stock offering aimed at bringing in just under $80 million to support the expected launch of its irritable bowel syndrome drug candidate, linaclotide.</description>
</item>
<item>
<title>iRobot share price falls 33 percent on defense outlook</title>
<author>Julie M. Donnelly, Boston Business Journal</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily41-iRobot-share-price-falls-33-percent-on-defense-outlook.html</link>
<pubDate>Thu, 09 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619980.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619980.jpg">
</media:content>
<description>IRobot Corp.’s stock has lost a third of its value, after the company announced it would likely lose a significant chunk of its revenue from military contracts in the current year, due to constrained Department of Defense budgets.  </description>
</item>
<item>
<title>SpaceClaim draws up a $4M new funding round</title>
<author>Rodney Brown</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily40-SpaceClaim-draws-up-a-4M-new-funding-round.html</link>
<pubDate>Thu, 09 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<description>Concord CAD software company SpaceClaim Corp. has raised $4 million in a new fundraising round according to an SEC document. CEO Chris Randles said the funds will help it expand distribution channels to keep up with rapid growth.   </description>
</item>
<item>
<title>Forsyth gets $750K grant from Gates Foundation</title>
<author>Lori Valigra</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily39-Forsyth-gets-750K-grant-from-Gates-Foundation.html</link>
<pubDate>Thu, 09 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<description>The Forsyth Institute said today that it will get a $750,000 grant to research tuberculosis (TB) biomarkers through the Bill &amp; Melinda Gates Foundation’s Grand Challenges in Global Health program, according to information provided by the institute.  </description>
</item>
<item>
<title>Hologic, Conceptus both file appeals in patent case</title>
<author>Rodney Brown</author>
<link>http://www.masshightech.com/stories/2012/02/06/daily38-Hologic-Conceptus-both-file-appeals-in-patent-case.html</link>
<pubDate>Thu, 09 Feb 2012 00:00:00 -0500</pubDate>
<source:pub>Mass High Tech: The Voice of New England Innovation</source:pub>
<media:thumbnail url="http://www.masshightech.com/resized-images/homepagelatestnews1619977.jpg" />
<media:content url="http://www.masshightech.com/resized-images/articlepage1619977.jpg">
</media:content>
<description>The legal fight between Hologic Inc. of Bedford and California firm Conceptus Inc. continues with Conceptus appealing a court’s ruling that denied its motion to stop Hologic from selling its Adiana permanent contraception system. In addition, Hologic filed an appeal of a jury verdict that found it had infringed on a Conceptus patent.   </description>
</item>
</channel>
</rss>

